The emerging importance of ribosomal dysfunction in the pathogenesis of hematologic disorders

References

• Josephs HW. Anaemia of infancy and early childhood. Medicine 1936;15:307.
   Google Scholar
• Diamond LK, Blackfan KD. Hypoplastic anemia. Am J Dis Child 1938;56:464.
   Google Scholar
• Orfali KA, Ohene-Abuakwa Y, Ball SE. Diamond Blackfan anaemia in the UK: clinical and genetic heterogeneity. Br J Haematol 2004;125:243–252.
   PubMed Web of Science ®Google Scholar
• Lipton JM, Ellis SR. Diamond-Blackfan anemia: diagnosis, treatment, and molecular pathogenesis. Hematol Oncol Clin North Am 2009;23:261–282.
   PubMed Web of Science ®Google Scholar
• Vlachos A, Muir E. How I treat Diamond-Blackfan anemia. Blood 2010;116:3715–3723.
   PubMed Web of Science ®Google Scholar
• Narla A, Ebert BL. Translational medicine: ribosomopathies. Blood 2011;118:4300–4301.
   PubMed Web of Science ®Google Scholar
• Vlachos A, Ball S, Dahl N, et al. Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference. Br J Haematol 2008;142:859–876.
   PubMed Web of Science ®Google Scholar
• Ellis SR, Gleizes PE. Diamond Blackfan anemia: ribosomal proteins going rogue. Semin Hematol 2011;48:89–96.
   Google Scholar
• Gazda HT, Preti M, Sheen MR, et al. Frameshift mutation in p53 regulator RPL26 is associated with multiple physical abnormalities and a specific pre-ribosomal RNA processing defect in diamond-blackfan anemia. Hum Mutat 2012;33:1037–1044.
   PubMed Web of Science ®Google Scholar
• Gazda HT, Sheen MR, Vlachos A, et al. Ribosomal protein L5 and L11 mutations are associated with cleft palate and abnormal thumbs in Diamond-Blackfan anemia patients. Am J Hum Genet 2008;83: 769–780.
   PubMed Web of Science ®Google Scholar
• Mirabello L, Ballew BJ, Neelam G, et al. RPS29 is mutated in a multi-case Diamond Blackfan anemia family. Blood 2012; 120(Suppl. 1):. Abstract 511.
   Google Scholar
• Farrar JE, Vlachos A, Atsidaftos E, et al. Ribosomal protein gene deletions in Diamond-Blackfan anemia. Blood 2011;118:6943–6951.
   PubMed Web of Science ®Google Scholar
• Kuramitsu M, Sato-Otsubo A, Morio T, et al. Extensive gene deletions in Japanese patients with Diamond-Blackfan anemia. Blood 2012;119:2376–2384.
   PubMed Web of Science ®Google Scholar
• Quarello P, Garelli E, Brusco A, et al. High frequency of ribosomal protein gene deletions in Italian Diamond-Blackfan anemia patients detected by multiplex ligation-dependent probe amplification assay. Haematologica 2012;97:1813–1817.
   PubMed Web of Science ®Google Scholar
• Sankaran VG, Ghazvinian R, Do R, et al. Exome sequencing identifies GATA1 mutations resulting in Diamond-Blackfan anemia. J Clin Invest 2012;122:2439–2443.
   PubMed Web of Science ®Google Scholar
• Gazda HT, Grabowska A, Merida-Long LB, et al. Ribosomal protein S24 gene is mutated in Diamond-Blackfan anemia. Am J Hum Genet 2006;79:1110–1118.
   PubMed Web of Science ®Google Scholar
• Cmejla R, Cmejlova J, Handrkova H, et al. Ribosomal protein S17 gene (RPS17) is mutated in Diamond-Blackfan anemia. Hum Mutat 2007;28:1178–1182.
   PubMed Web of Science ®Google Scholar
• Moniz H, Gastou M, Leblanc T, et al. Primary hematopoietic cells from DBA patients with mutations in RPL11 and RPS19 genes exhibit distinct erythroid phenotype in vitro. Cell Death Dis 2012;3:e356.
   PubMed Web of Science ®Google Scholar
• O’Donohue MF, Choesmel V, Faubladier M, et al. Functional dichotomy of ribosomal proteins during the synthesis of mammalian 40S ribosomal subunits. J Cell Biol 2010;190:853–866.
   PubMed Web of Science ®Google Scholar
• Choesmel V, Bacqueville D, Rouquette J, et al. Impaired ribosome biogenesis in Diamond-Blackfan anemia. Blood 2007;109:1275–1283.
   PubMed Web of Science ®Google Scholar
• Choesmel V, Fribourg S, Aguissa-Toure AH, et al. Mutation of ribosomal protein RPS24 in Diamond-Blackfan anemia results in a ribosome biogenesis disorder. Hum Mol Genet 2008;17:1253–1263.
   PubMed Web of Science ®Google Scholar
• Flygare J, Aspesi A, Bailey JC, et al. Human RPS19, the gene mutated in Diamond-Blackfan anemia, encodes a ribosomal protein required for the maturation of 40S ribosomal subunits. Blood 2007; 109:980–986.
   PubMed Web of Science ®Google Scholar
• Idol RA, Robledo S, Du HY, et al. Cells depleted for RPS19, a protein associated with Diamond Blackfan anemia, show defects in 18S ribosomal RNA synthesis and small ribosomal subunit production. Blood Cells Mol Dis 2007;39:35–43.
   PubMed Web of Science ®Google Scholar
• Fumagalli S, Di Cara A, Neb-Gulati A, et al. Absence of nucleolar disruption after impairment of 40S ribosome biogenesis reveals an rpL11-translation-dependent mechanism of p53 induction. Nat Cell Biol 2009;11:501–508.
   PubMed Web of Science ®Google Scholar
• Fumagalli S, Ivanenkov VV, Teng T, et al. Suprainduction of p53 by disruption of 40S and 60S ribosome biogenesis leads to the activation of a novel G2/M checkpoint. Genes Dev 2012;26:1028–1040.
   PubMed Web of Science ®Google Scholar
• Robledo S, Idol RA, Crimmins DL, et al. The role of human ribosomal proteins in the maturation of rRNA and ribosome production. RNA 2008;14:1918–1929.
   PubMed Web of Science ®Google Scholar
• Van den Berghe H, Cassiman JJ, David G, et al. Distinct haematological disorder with deletion of long arm of no. 5 chromosome. Nature 1974;251:437–438.
   PubMed Web of Science ®Google Scholar
• Ebert BL. Molecular dissection of the 5q deletion in myelodysplastic syndrome. Semin Oncol 2011;38:621–626.
   PubMed Web of Science ®Google Scholar
• Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002;100:2292–2302.
   PubMed Web of Science ®Google Scholar
• List A, Dewald G, Bennett J, et al. Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion. N Engl J Med 2006;355:1456–1465.
   PubMed Web of Science ®Google Scholar
• Fenaux P, Giagounidis A, Selleslag D, et al. A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with low-/intermediate-1-risk myelodysplastic syndromes with del5q. Blood 2011;118:3765–3776.
   PubMed Web of Science ®Google Scholar
• Ebert BL, Pretz J, Bosco J, et al. Identification of RPS14 as a 5q- syndrome gene by RNA interference screen. Nature 2008;451: 335–339.
   PubMed Web of Science ®Google Scholar
• Moutouh-de Parseval LA, Verhelle D, Glezer E, et al. Pomalidomide and lenalidomide regulate erythropoiesis and fetal hemoglobin production in human CD34 + cells. J Clin Invest 2008;118:248–258.
   PubMed Web of Science ®Google Scholar
• Narla A, Dutt S, McAuley JR, et al. Dexamethasone and lenalidomide have distinct functional effects on erythropoiesis. Blood 2011;118:2296–2304.
   PubMed Web of Science ®Google Scholar
• Joslin JM, Fernald AA, Tennant TR, et al. Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders. Blood 2007;110:719–726.
   PubMed Web of Science ®Google Scholar
• Kumar MNA, et al. Coordinate loss of a microRNA miR 145 and a protein-coding gene RPS14 cooperate in the pathogenesis of 5q- syndrome. Blood 2009;114(Suppl. 1): Abstract 947.
   Google Scholar
• Min IM, Pietramaggiori G, Kim FS, et al. The transcription factor EGR1 controls both the proliferation and localization of hematopoietic stem cells. Cell Stem Cell 2008;2:380–391.
   PubMedGoogle Scholar
• Starczynowski DT, Kuchenbauer F, Argiropoulos B, et al. Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype. Nat Med 2010;16:49–58.
   PubMed Web of Science ®Google Scholar
• Shwachman H, Diamond LK, Oski FA, et al. The syndrome of pancreatic insufficiency and bone marrow dysfunction. J Pediatr 1964;65:645–663.
   PubMed Web of Science ®Google Scholar
• Burroughs L, Woolfrey A, Shimamura A. Shwachman-Diamond syndrome: a review of the clinical presentation, molecular pathogenesis, diagnosis, and treatment. Hematol Oncol Clin North Am 2009;23:233–248.
   PubMed Web of Science ®Google Scholar
• Donadieu J, Leblanc T, Bader Meunier B, et al. Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group. Haematologica 2005;90:45–53.
   Google Scholar
• Ganapathi KA, Shimamura A. Ribosomal dysfunction and inherited marrow failure. Br J Haematol 2008;141:376–387.
   PubMed Web of Science ®Google Scholar
• Boocock GR, Morrison JA, Popovic M, et al. Mutations in SBDS are associated with Shwachman-Diamond syndrome. Nat Genet 2003;33:97–101.
   PubMed Web of Science ®Google Scholar
• Finch AJ, Hilcenko C, Basse N, et al. Uncoupling of GTP hydrolysis from eIF6 release on the ribosome causes Shwachman-Diamond syndrome. Genes Dev 2011;25:917–929.
   PubMed Web of Science ®Google Scholar
• Menne TF, Goyenechea B, Sanchez-Puig N, et al. The Shwachman-Bodian-Diamond syndrome protein mediates translational activation of ribosomes in yeast. Nat Genet 2007;39:486–495.
   PubMed Web of Science ®Google Scholar
• Wong CC, Traynor D, Basse N, et al. Defective ribosome assembly in Shwachman-Diamond syndrome. Blood 2011;118:4305–4312.
   PubMed Web of Science ®Google Scholar
• Rujkijyanont P, Adams SL, Beyene J, et al. Bone marrow cells from patients with Shwachman-Diamond syndrome abnormally express genes involved in ribosome biogenesis and RNA processing. Br J Haematol 2009;145:806–815.
   PubMed Web of Science ®Google Scholar
• Burwick N, Coats SA, Nakamura T, et al. Impaired ribosomal subunit association in Shwachman-Diamond syndrome. Blood 2012;120:5143–5152.
   PubMed Web of Science ®Google Scholar
• Austin KM, Gupta ML, Coats SA, et al. Mitotic spindle destabilization and genomic instability in Shwachman-Diamond syndrome. J Clin Invest 2008;118:1511–1518.
   PubMed Web of Science ®Google Scholar
• Orelio C, Verkuijlen P, Geissler J, et al. SBDS expression and localization at the mitotic spindle in human myeloid progenitors. PLoS One 2009;4:e7084.
   Web of Science ®Google Scholar
• Dokal I, Vulliamy T. Dyskeratosis congenita: its link to telomerase and aplastic anaemia. Blood Rev 2003;17:217–225.
   PubMed Web of Science ®Google Scholar
• Mason PJ, Bessler M. The genetics of dyskeratosis congenita. Cancer Genet 2011;204:635–645.
   Google Scholar
• Savage SA, Alter BP. Dyskeratosis congenita. Hematol Oncol Clin North Am 2009;23:215–231.
   PubMed Web of Science ®Google Scholar
• Vulliamy T, Beswick R, Kirwan M, et al. Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita. Proc Natl Acad Sci USA 2008;105:8073–8078.
   PubMed Web of Science ®Google Scholar
• Vulliamy TJ, Marrone A, Knight SW, et al. Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation. Blood 2006;107:2680–2685.
   PubMed Web of Science ®Google Scholar
• Marrone A, Walne A, Tamary H, et al. Telomerase reverse-transcriptase homozygous mutations in autosomal recessive dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome. Blood 2007;110:4198–4205.
   PubMed Web of Science ®Google Scholar
• Mochizuki Y, He J, Kulkarni S, et al. Mouse dyskerin mutations affect accumulation of telomerase RNA and small nucleolar RNA, telomerase activity, and ribosomal RNA processing. Proc Natl Acad Sci USA 2004;101:10756–10761.
   PubMed Web of Science ®Google Scholar
• Wong JM, Collins K. Telomerase RNA level limits telomere maintenance in X-linked dyskeratosis congenita. Genes Dev 2006;20:2848–2858.
   PubMed Web of Science ®Google Scholar
• Ruggero D, Grisendi S, Piazza F, et al. Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification. Science 2003;299:259–262.
   PubMed Web of Science ®Google Scholar
• McKusick VA, Eldridge R, Hostetler JA, et al. Dwarfism in the Amish. II. Cartilage-hair hypoplasia. Bull Johns Hopkins Hosp 1965;116:285–326.
   PubMedGoogle Scholar
• Makitie O. Cartilage-hair hypoplasia in Finland: epidemiological and genetic aspects of 107 patients. J Med Genet 1992;29:652–655.
   PubMed Web of Science ®Google Scholar
• Thiel CT, Rauch A. The molecular basis of the cartilage-hair hypoplasia-anauxetic dysplasia spectrum. Best Pract Res Clin Endocrinol Metab 2011;25:131–142.
   PubMed Web of Science ®Google Scholar
• Berthet F, Siegrist CA, Ozsahin H, et al. Bone marrow transplantation in cartilage-hair hypoplasia: correction of the immunodeficiency but not of the chondrodysplasia. Eur J Pediatr 1996; 155:286–290.
   PubMed Web of Science ®Google Scholar
• Ridanpaa M, van Eenennaam H, Pelin K, et al. Mutations in the RNA component of RNase MRP cause a pleiotropic human disease, cartilage-hair hypoplasia. Cell 2001;104:195–203.
   PubMed Web of Science ®Google Scholar
• Hermanns P, Tran A, Munivez E, et al. RMRP mutations in cartilage-hair hypoplasia. Am J Med Genet A 2006;140:2121–2130.
   PubMed Web of Science ®Google Scholar
• Welting TJ, van Venrooij WJ, Pruijn GJ. Mutual interactions between subunits of the human RNase MRP ribonucleoprotein complex. Nucleic Acids Res 2004;32:2138–2146.
   PubMed Web of Science ®Google Scholar
• Sarafan-Vasseur N, Lamy A, Bourguignon J, et al. Overexpression of B-type cyclins alters chromosomal segregation. Oncogene 2002; 21:2051–2057.
   PubMed Web of Science ®Google Scholar
• Thiel CT, Horn D, Zabel B, et al. Severely incapacitating mutations in patients with extreme short stature identify RNA-processing endoribonuclease RMRP as an essential cell growth regulator. Am J Hum Genet 2005;77:795–806.
   PubMed Web of Science ®Google Scholar
• Maida Y, Yasukawa M, Furuuchi M, et al. An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA. Nature 2009;461: 230–235.
   PubMed Web of Science ®Google Scholar
• Sakai D, Trainor PA. Treacher Collins syndrome: unmasking the role of Tcof1/treacle. Int J Biochem Cell Biol 2009;41:1229–1232.
   PubMed Web of Science ®Google Scholar
• Treacher-Collins E. Case with symmetrical congenital notches in the outer part of each lower lid and defective development of the malar bones. Trans Opthalmol Soc UK 1900;20:90.
   Google Scholar
• Valdez BC, Henning D, So RB, et al. The Treacher Collins syndrome (TCOF1) gene product is involved in ribosomal DNA gene transcription by interacting with upstream binding factor. Proc Natl Acad Sci USA 2004;101:10709–10714.
   PubMed Web of Science ®Google Scholar
• Dauwerse JG, Dixon J, Seland S, et al. Mutations in genes encoding subunits of RNA polymerases I and III cause Treacher Collins syndrome. Nat Genet 2011;43:20–22.
   PubMed Web of Science ®Google Scholar
• Jaako P, Debnath S, Olsson K, et al. Dietary L-leucine improves the anemia in a mouse model for Diamond-Blackfan anemia. Blood 2012;120:2225–2228.
   PubMed Web of Science ®Google Scholar
• Pospisilova D, Cmejlova J, Hak J, et al. Successful treatment of a Diamond-Blackfan anemia patient with amino acid leucine. Haematologica 2007;92:e66–e67.
   Web of Science ®Google Scholar
• Sjogren SE, Flygare J. Progress towards mechanism-based treatment for Diamond-Blackfan anemia. Sci World J 2012;2012:184362.
   Web of Science ®Google Scholar
• Miyake K, Utsugisawa T, Flygare J, et al. Ribosomal protein S19 deficiency leads to reduced proliferation and increased apoptosis but does not affect terminal erythroid differentiation in a cell line model of Diamond-Blackfan anemia. Stem Cells 2008;26:323–329.
   PubMed Web of Science ®Google Scholar
• Ohene-Abuakwa Y, Orfali KA, Marius C, et al. Two-phase culture in Diamond Blackfan anemia: localization of erythroid defect. Blood 2005;105:838–846.
   PubMed Web of Science ®Google Scholar
• Ebert BL, Lee MM, Pretz JL, et al. An RNA interference model of RPS19 deficiency in Diamond-Blackfan anemia recapitulates defective hematopoiesis and rescue by dexamethasone: identification of dexamethasone-responsive genes by microarray. Blood 2005;105: 4620–4626.
   PubMed Web of Science ®Google Scholar
• Flygare J, Kiefer T, Miyake K, et al. Deficiency of ribosomal protein S19 in CD34 +cells generated by siRNA blocks erythroid development and mimics defects seen in Diamond-Blackfan anemia. Blood 2005;105:4627–4634.
   PubMed Web of Science ®Google Scholar
• Hamaguchi I, Ooka A, Brun A, et al. Gene transfer improves erythroid development in ribosomal protein S19-deficient Diamond-Blackfan anemia. Blood 2002;100:2724–2731.
   PubMed Web of Science ®Google Scholar
• Flygare J, Olsson K, Richter J, et al. Gene therapy of Diamond Blackfan anemia CD34(+) cells leads to improved erythroid development and engraftment following transplantation. Exp Hematol 2008;36:1428–1435.
   PubMed Web of Science ®Google Scholar
• Zivny J, Jelinek J, Pospisilova D, et al. Diamond Blackfan anemia stem cells fail to repopulate erythropoiesis in NOD/SCID mice. Blood Cells Mol Dis 2003;31:93–97.
   PubMed Web of Science ®Google Scholar
• Danilova N, Sakamoto KM, Lin S. Ribosomal protein S19 deficiency in zebrafish leads to developmental abnormalities and defective erythropoiesis through activation of p53 protein family. Blood 2008;112:5228–5237.
   PubMed Web of Science ®Google Scholar
• Payne EM, Virgilio M, Narla A, et al. L-leucine improves the anemia and developmental defects associated with Diamond-Blackfan anemia and del(5q) MDS by activating the mTOR pathway. Blood 2012;120:2214–2224.
   Google Scholar
• Uechi T, Nakajima Y, Chakraborty A, et al. Deficiency of ribosomal protein S19 during early embryogenesis leads to reduction of erythrocytes in a zebrafish model of Diamond-Blackfan anemia. Hum Mol Genet 2008;17:3204–3211.
   PubMed Web of Science ®Google Scholar
• Chakraborty A, Uechi T, Higa S, et al. Loss of ribosomal protein L11 affects zebrafish embryonic development through a p53-dependent apoptotic response. PLoS One 2009;4:e4152.
   PubMed Web of Science ®Google Scholar
• Taylor AM, Humphries JM, White RM, et al. Hematopoietic defects in rps29 mutant zebrafish depend upon p53 activation. Exp Hematol 2012;40:228–237 e225.
   Google Scholar
• Amsterdam A, Nissen RM, Sun Z, et al. Identification of 315 genes essential for early zebrafish development. Proc Natl Acad Sci USA 2004;101:12792–12797.
   PubMed Web of Science ®Google Scholar
• Golling G, Amsterdam A, Sun Z, et al. Insertional mutagenesis in zebrafish rapidly identifies genes essential for early vertebrate development. Nat Genet 2002;31:135–140.
   PubMed Web of Science ®Google Scholar
• Amsterdam A, Sadler KC, Lai K, et al. Many ribosomal protein genes are cancer genes in zebrafish. PLoS Biol 2004;2:E139.
   PubMed Web of Science ®Google Scholar
• Alter BP, Giri N, Savage SA, et al. Cancer in dyskeratosis congenita. Blood 2009;113:6549–6557.
   PubMed Web of Science ®Google Scholar
• Ebert BL. Deletion 5q in myelodysplastic syndrome: a paradigm for the study of hemizygous deletions in cancer. Leukemia 2009;23: 1252–1256.
   PubMed Web of Science ®Google Scholar
• Montanaro L. Dyskerin and cancer: more than telomerase. The defect in mRNA translation helps in explaining how a proliferative defect leads to cancer. J Pathol 2010;222:345–349.
   Google Scholar
• Vlachos A, Rosenberg PS, Atsidaftos E, et al. Incidence of neoplasia in Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry. Blood 2012;119:3815–3819.
   PubMed Web of Science ®Google Scholar
• Anderson SJ, Lauritsen JP, Hartman MG, et al. Ablation of ribosomal protein L22 selectively impairs alphabeta T cell development by activation of a p53-dependent checkpoint. Immunity 2007;26:759–772.
   PubMed Web of Science ®Google Scholar
• Barkic M, Crnomarkovic S, Grabusic K, et al. The p53 tumor suppressor causes congenital malformations in Rpl24-deficient mice and promotes their survival. Mol Cell Biol 2009;29:2489–2504.
   PubMed Web of Science ®Google Scholar
• Barlow JL, Drynan LF, Hewett DR, et al. A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q- syndrome. Nat Med 2010;16:59–66.
   PubMed Web of Science ®Google Scholar
• Gu BW, Bessler M, Mason PJ. A pathogenic dyskerin mutation impairs proliferation and activates a DNA damage response independent of telomere length in mice. Proc Natl Acad Sci USA 2008;105:10173–10178.
   PubMed Web of Science ®Google Scholar
• Jaako P, Flygare J, Olsson K, et al. Mice with ribosomal protein S19 deficiency develop bone marrow failure and symptoms like patients with Diamond-Blackfan anemia. Blood 2011;118:6087–6096.
   PubMed Web of Science ®Google Scholar
• Jones NC, Lynn ML, Gaudenz K, et al. Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function. Nat Med 2008;14:125–133.
   PubMed Web of Science ®Google Scholar
• Kondrashov N, Pusic A, Stumpf CR, et al. Ribosome-mediated specificity in Hox mRNA translation and vertebrate tissue patterning. Cell 2011;145:383–397.
   PubMed Web of Science ®Google Scholar
• Matsson H, Davey EJ, Draptchinskaia N, et al. Targeted disruption of the ribosomal protein S19 gene is lethal prior to implantation. Mol Cell Biol 2004;24:4032–4037.
   PubMed Web of Science ®Google Scholar
• McGowan KA, Li JZ, Park CY, et al. Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects. Nat Genet 2008;40: 963–970.
   PubMed Web of Science ®Google Scholar
• McGowan KA, Pang WW, Bhardwaj R, et al. Reduced ribosomal protein gene dosage and p53 activation in low-risk myelodysplastic syndrome. Blood 2011;118:3622–3633.
   PubMed Web of Science ®Google Scholar
• Oliver ER, Saunders TL, Tarle SA, et al. Ribosomal protein L24 defect in belly spot and tail (Bst), a mouse Minute. Development 2004;131:3907–3920.
   PubMedGoogle Scholar
• Sulic S, Panic L, Barkic M, et al. Inactivation of S6 ribosomal protein gene in T lymphocytes activates a p53-dependent checkpoint response. Genes Dev 2005;19:3070–3082.
   PubMed Web of Science ®Google Scholar
• Volarevic S, Stewart MJ, Ledermann B, et al. Proliferation, but not growth, blocked by conditional deletion of 40S ribosomal protein S6. Science 2000;288:2045–2047.
   PubMed Web of Science ®Google Scholar
• Zhang S, Shi M, Hui CC, et al. Loss of the mouse ortholog of the Shwachman-Diamond syndrome gene (Sbds) results in early embryonic lethality. Mol Cell Biol 2006;26:6656–6663.
   PubMed Web of Science ®Google Scholar
• Devlin EE, Dacosta L, Mohandas N, et al. A transgenic mouse model demonstrates a dominant negative effect of a point mutation in the RPS19 gene associated with Diamond-Blackfan anemia. Blood 2010;116:2826–2835.
   PubMed Web of Science ®Google Scholar
• Talos F, Moll UM. Role of the p53 family in stabilizing the genome and preventing polyploidization. Adv Exp Med Biol 2010; 676:73–91.
   Google Scholar
• Pereboom TC, van Weele LJ, Bondt A, et al. A zebrafish model of dyskeratosis congenita reveals hematopoietic stem cell formation failure resulting from ribosomal protein-mediated p53 stabilization. Blood 2011;118:5458–5465.
   Google Scholar
• Dutt S, Narla A, Lin K, et al. Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells. Blood 2011;117:2567–2576.
   PubMed Web of Science ®Google Scholar
• Chen D, Zhang Z, Li M, et al. Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function. Oncogene 2007;26: 5029–5037.
   PubMed Web of Science ®Google Scholar
• Dai MS, Lu H. Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5. J Biol Chem 2004;279: 44475–44482.
   PubMed Web of Science ®Google Scholar
• Dai MS, Zeng SX, Jin Y, et al. Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition. Mol Cell Biol 2004; 24:7654–7668.
   PubMed Web of Science ®Google Scholar
• Jin A, Itahana K, O’Keefe K, et al. Inhibition of HDM2 and activation of p53 by ribosomal protein L23. Mol Cell Biol 2004;24: 7669–7680.
   PubMed Web of Science ®Google Scholar
• Lohrum MA, Ludwig RL, Kubbutat MH, et al. Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell 2003;3: 577–587.
   PubMed Web of Science ®Google Scholar
• Ofir-Rosenfeld Y, Boggs K, Michael D, et al. Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26. Mol Cell 2008;32:180–189.
   PubMed Web of Science ®Google Scholar
• Zhang X, Wang W, Wang H, et al. Identification of ribosomal protein S25 (RPS25)-MDM2-p53 regulatory feedback loop. Oncogene 2013;32:2782–2791.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang J, Yuan Y, et al. Negative regulation of HDM2 to attenuate p53 degradation by ribosomal protein L26. Nucleic Acids Res 2010;38:6544–6554.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wolf GW, Bhat K, et al. Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway. Mol Cell Biol 2003;23: 8902–8912.
   PubMed Web of Science ®Google Scholar
• Zhou X, Hao Q, Liao J, et al. Ribosomal protein S14 unties the MDM2-p53 loop upon ribosomal stress. Oncogene 2013;32: 388–396.
   PubMed Web of Science ®Google Scholar
• Macias E, Jin A, Deisenroth C, et al. An ARF-independent c-MYC-activated tumor suppression pathway mediated by ribosomal protein-Mdm2 Interaction. Cancer Cell 2010;18:231–243.
   PubMed Web of Science ®Google Scholar
• Takagi M, Absalon MJ, McLure KG, et al. Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin. Cell 2005;123:49–63.
   PubMed Web of Science ®Google Scholar
• Lajtha LG, Oliver R. A kinetic model of the erythron. Proc R Soc Med 1961;54:369–371.
   PubMedGoogle Scholar
• Keel SB, Doty RT, Yang Z, et al. A heme export protein is required for red blood cell differentiation and iron homeostasis. Science 2008;319:825–828.
   PubMed Web of Science ®Google Scholar
• Quigley JG, Yang Z, Worthington MT, et al. Identification of a human heme exporter that is essential for erythropoiesis. Cell 2004;118:757–766.
   PubMed Web of Science ®Google Scholar
• Alter BP, Giri N, Savage SA, et al. Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study. Br J Haematol 2010;150: 179–188.
   PubMed Web of Science ®Google Scholar
• Freedman MH, Alter BP. Risk of myelodysplastic syndrome and acute myeloid leukemia in congenital neutropenias. Semin Hematol 2002;39:128–133.
   PubMed Web of Science ®Google Scholar
• Taskinen M, Kananen K, Valimaki M, et al. Risk factors for reduced areal bone mineral density in young adults with stem cell transplantation in childhood. Pediatr Transplant 2006;10: 90–97.
   PubMed Web of Science ®Google Scholar
• Grummitt CG, Townsley FM, Johnson CM, et al. Structural consequences of nucleophosmin mutations in acute myeloid leukemia. J Biol Chem 2008;283:23326–23332.
   PubMedGoogle Scholar
• Naoe T, Suzuki T, Kiyoi H, et al. Nucleophosmin: a versatile molecule associated with hematological malignancies. Cancer Sci 2006;97:963–969.
   PubMed Web of Science ®Google Scholar
• Patel JP, Gonen M, Figueroa ME, et al. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N Engl J Med 2012;366:1079–1089.
   PubMed Web of Science ®Google Scholar
• Grisendi S, Bernardi R, Rossi M, et al. Role of nucleophosmin in embryonic development and tumorigenesis. Nature 2005;437: 147–153.
   PubMed Web of Science ®Google Scholar
• De Keersmaecker K, Atak ZK, Li N, et al. Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia. Nat Genet 2013;45: 186–190.
   PubMed Web of Science ®Google Scholar
• Rao S, Lee SY, Gutierrez A, et al. Inactivation of ribosomal protein L22 promotes transformation by induction of the stemness factor, Lin28B. Blood 2012;120:3764–3773.
   PubMed Web of Science ®Google Scholar
• MacInnes AW, Amsterdam A, Whittaker CA, et al. Loss of p53 synthesis in zebrafish tumors with ribosomal protein gene mutations. Proc Natl Acad Sci USA 2008;105:10408–10413.
   PubMed Web of Science ®Google Scholar
• Gazda HT, Kho AT, Sanoudou D, et al. Defective ribosomal protein gene expression alters transcription, translation, apoptosis, and oncogenic pathways in Diamond-Blackfan anemia. Stem Cells 2006;24:2034–2044.
   PubMed Web of Science ®Google Scholar
• Ruggero D, Pandolfi PP. Does the ribosome translate cancer?. Nat Rev Cancer 2003;3:179–192.
   PubMed Web of Science ®Google Scholar